In continuation of the letter dated February 1, 2019, Jubilant LifeScience has informed about the copies of the Unaudited Consolidated Financial Results for the quarter ended December 31, 2018 published on February 2, 2019 in Mint (English) and Hindustan (Hindi).
The above information is a part of company’s filings submitted to BSE.